Secukinumab is effective in reducing dactylitis and enthesitis using multiple measures in patients with psoriatic arthritis: Results of a phase 3 randomized, multicenter, double-blind, placebo-controlled study (FUTURE 2)

Mease P.; Kirkham B.; McInnes I. B.; Kremer J.; Kandala S.; Pricop L.; Mpofu S.

首页> 外文期刊>The Journal of investigative dermatology. >Secukinumab is effective in reducing dactylitis and enthesitis using multiple measures in patients with psoriatic arthritis: Results of a phase 3 randomized, multicenter, double-blind, placebo-controlled study (FUTURE 2)

【24h】

Secukinumab is effective in reducing dactylitis and enthesitis using multiple measures in patients with psoriatic arthritis: Results of a phase 3 randomized, multicenter, double-blind, placebo-controlled study (FUTURE 2)

机译：在多种银屑病性关节炎患者中，Secukinumab可有效减少多种疾病，从而减轻牙根炎和脑炎：一项3期随机，多中心，双盲，安慰剂对照研究的结果（未来2）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of investigative dermatology.》 |2015年第3期|共1页
作者
Mease P.; Kirkham B.; McInnes I. B.; Kremer J.; Kandala S.; Pricop L.; Mpofu S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类皮肤病学与性病学;
关键词

相似文献

外文文献
中文文献

1. Secukinumab is effective in reducing dactylitis and enthesitis using multiple measures in patients with psoriatic arthritis: Results of a phase 3 randomized, multicenter, double-blind, placebo-controlled study (FUTURE 2) [J] . Mease P., Kirkham B., McInnes I. B., The Journal of investigative dermatology. . 2015,第Suppla3期

机译：在多种银屑病性关节炎患者中，Secukinumab可有效减少多种疾病，从而减轻牙根炎和脑炎：一项3期随机，多中心，双盲，安慰剂对照研究的结果（未来2）
2. Secukinumab improves active psoriatic arthritis and inhibits radiographic progression: Results of a phase 3 randomized, multicenter, double-blind, placebo-controlled study [J] . Mease P., McInnes I. B., Kirkham B., The Journal of investigative dermatology. . 2015,第Suppla3期

机译：Secukinumab改善活动性银屑病关节炎并抑制影像学进展：一项3期随机，多中心，双盲，安慰剂对照研究的结果
3. Secukinumab, a Human Anti-Interleukin-17A Monoclonal Antibody, Improves Active Psoriatic Arthritis: 24-Week Efficacy and Safety Data from a Phase 3 Randomized, Multicenter, Double-Blind, Placebo-Controlled Study Using Subcutaneous Dosing. [J] . McInnes Iain B., Mease Philip J., Kirkham Bruce, Arthritis & rheumatology. . 2014,第12期

机译：Secukinumab是一种人类抗白介素17A单克隆抗体，可改善活动型银屑病关节炎：使用皮下给药的一项3期随机，多中心，双盲，安慰剂对照研究的24周疗效和安全性数据。
4. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
5. Impact of guselkumab an interleukin-23 p19 subunit inhibitor on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis: results from a randomised placebo-controlled phase II study [O] . Philip J Mease, Dafna D Gladman, Atul Deodhar, 2020

机译：中胞素蛋白-33 p19亚基抑制剂的影响对中度至严重银屑病关节炎患者肠炎和直仙炎的影响：来自随机安慰剂控制II期研究的结果
6. 073. SECUKINUMAB PROVIDES RAPID AND SUSTAINED REDUCTIONS IN DACTYLITIS AND ENTHESITIS IN PATIENTS WITH PSORIATIC ARTHRITIS: ANALYSIS OF DATA FROM THE PHASE 3 RANDOMIZED, MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED FUTURE 2 STUDY [O] . Bruce Kirkham, Philip J. Mease, Iain B. McInnes 2017

机译：073. Secukinumab在银屑病关节炎患者中提供快速和持续减少患者：分析3阶段随机，多期，双盲，安慰剂控制未来2研究的数据

Secukinumab is effective in reducing dactylitis and enthesitis using multiple measures in patients with psoriatic arthritis: Results of a phase 3 randomized, multicenter, double-blind, placebo-controlled study (FUTURE 2)

著录项

相似文献

相关主题

期刊订阅